a close up of a pen


Syneos Health, Inc. acquired by a private investment consortium for approximately US$7.1 billion

On September 28,2023, Syneos Health, Inc. (Nasdaq: SYNH) (Syneos Health or the Company), a leading fully integrated biopharmaceutical solutions organization, announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital.

As a result of the transaction, Syneos Health is now a privately held company. With the support of its new private investors, the Company will be poised to further accelerate its transformation, fuel investments in technology that better differentiate its integrated solutions and expand its commitment to better serve customers.

Under the terms of the transaction, Syneos Health stockholders will receive $43.00 in cash for each share of Syneos Health common stock they hold (without interest and subject to any applicable withholding taxes or other amounts required to be withheld under applicable law).

BLG acted as Canadian counsel to the consortium with a team led by Ryan Tomicic that included Doug Copland, Manon Gauthier, Julie Gauthier, Bradley Freedman, Emma Carbonneau, Morgane Besner, Fabio Colias, Valérie Olivier (Corporate); Jon Kristinarson (Securities); Tommy Hong and Shwan Shaker (Labour & Employment); Andrew Reid Workman and Line Abecassis (Commercial Real Estate).